Edition:
India

People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

3.90USD
11:11pm IST
Change (% chg)

$0.09 (+2.23%)
Prev Close
$3.82
Open
$3.76
Day's High
$3.99
Day's Low
$3.76
Volume
65,960
Avg. Vol
308,399
52-wk High
$5.78
52-wk Low
$2.40

Konidaris, Anastasios 

Mr. Anastasios G. Konidaris serves as Chief Financial Officer, Senior Vice President of the Company. He joins the Company from Alcresta Pharmaceuticals, LLC, a specialty pharmaceutical company, where he has served as Executive Vice President and Chief Financial Officer since March 2016. Prior to joining Alcresta Pharmaceuticals, Mr. Konidaris served as Senior Vice President and Chief Financial Officer of Ikaria, Inc., a biotherapeutics company, from October 2011 to May 2015. From 2007 to May 2015, Mr. Konidaris served as Senior Vice President and Chief Financial Officer at Dun & Bradstreet Corporation, a leading commercial information services company, where he also served as Principal Accounting Officer and led the Global Finance Operations from 2005 to 2007. From 2003 to 2005, Mr. Konidaris served as Group Vice President of the Global Pharmaceutical and Global Diversified Products Groups at Schering-Plough Corporation, a pharmaceutical company. Earlier in his career, Mr. Konidaris held senior financial and operational positions of increasing responsibility at the Pharmacia Corporation, Rhone-Poulenc Rorer, Novartis Corporation and Bristol-Myers Squibb Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --